XML 76 R49.htm IDEA: XBRL DOCUMENT v3.25.4
Organization, Consolidation and Presentation of Financial Statements (Tables)
 12 Months Ended
Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Summary of Condensed Consolidated Balance Sheets
Significant related party transactions included in the consolidated balance sheet, excluding the Company’s investments and equity method investments, are summarized below (in thousands):
As of December 31,
20252024
Deferred revenue, current and non-current:
Allonnia$36,495 $36,495 
Arcaea28,413 28,413 
BiomEdit— 7,583 
Genomatica— 564 
$64,908 $73,055 
Significant related party transactions included in the consolidated statements of operations and comprehensive loss, excluding the losses on the Company’s investments and equity method investments, are summarized below (in thousands):
Year Ended December 31,
202520242023
Cell Engineering revenue:
Motif FoodWorks$— $45,445 $6,660 
Arcaea— 4,653 6,024 
Genomatica564 1,453 4,232 
Ayana Bio637 1,028 1,323 
BiomEdit7,583 197 2,171 
Verb Biotics— — 584 
Allonnia— 126 523 
Other equity investees— 139 705 
$8,784 $53,041 $22,222